Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Evaluating ultrasound-guided thermal ablation for benign thyroid nodules

Official title: The Clinical Outcomes and Artificial Intelligence Prediction Model of Ultrasound-guided Thermal Ablation for the Treatment of Benign Thyroid Nodules:A Multicenter Prospective Study

Run by Chinese PLA General Hospital · NCT06340945 · Data updated 2026-11-12

This study is testing if a new ultrasound-guided treatment can safely shrink benign thyroid nodules and help people feel better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1500 (estimated)
SponsorChinese PLA General Hospital
Academic / other
Drugs / interventionsradiation
Locations1 site (Beijing)
StatusRecruiting
StartedApril 1, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2029
Registry record updatedMarch 19, 2026
Trial IDNCT06340945 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with confirmed benign thyroid nodules who experience cosmetic or symptomatic issues and are not suitable for surgery.

Probably not a fit

Patients with malignant findings on biopsy or those with specific ultrasound features indicating malignancy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the clinical outcomes of ultrasound-guided thermal ablation as a treatment for benign thyroid nodules. It will also focus on developing and validating an artificial intelligence model to predict the outcomes of this treatment. Participants will undergo thermal ablation, and their progress will be monitored over a follow-up period of at least six months. The study seeks to provide insights into the effectiveness and safety of this minimally invasive procedure.

Why it matters

Potential benefit: If successful, this treatment could offer a less invasive option for patients with benign thyroid nodules, potentially improving their quality of life.

How similar studies have gone: Other studies have shown promising results with ultrasound-guided thermal ablation for similar conditions, indicating a potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \[1\]confirmation of benign nodule status on two separate fine- needle aspiration (FNA) or core-needle biopsy (CNB) \[2\]no suspicious malignant features on ultrasound examination \[3\]report of cosmetic and/ or symptomatic problems or concern of nodules growing rapidly or malignant transformation \[4\]refusal or ineligibility for surgery \[5\]follow-up time ≥6months

Exclusion Criteria:

1. follicular neoplasm or malignancy findings on biopsy
2. nodules with benign result on biopsy had suspicious of malignancy in US, including marked hypoechoic, ill-defined margins, taller-than-wide shape or microcalcifications
3. patients with cystic nodules
4. patients with contra-lateral vocal cord par- alysis
5. previous radiation to the head and neck
6. ; follow- up time less than 6 months

Where it's running

  • Chinese PLA General Hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.